OmegaPoint Partners, LLC – Trademark Portfolio

Entity Type: 16

OmegaPoint Partners, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OMEGAPOINT and VIRUSCHAIN. The owner is based in Altamonte Springs, FL.

1070 Montgomery Road

Altamonte Springs, FL 32714

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OmegaPoint Partners, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does OmegaPoint Partners, LLC have?

OmegaPoint Partners, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does OmegaPoint Partners, LLC file in?

OmegaPoint Partners, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What are OmegaPoint Partners, LLC's most well-known trademarks?

OmegaPoint Partners, LLC's registered trademark portfolio includes well-known marks such as OMEGAPOINT and VIRUSCHAIN. These are among 2 currently registered trademarks in the portfolio.

What is OmegaPoint Partners, LLC's trademark registration success rate?

OmegaPoint Partners, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.